Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Legal

Latest News

March 1st 2006
Legal: Hey, Good Lookin': Sex Discrimination in Hiring Reps
By James McDonald, Jr.

Drug manufacturers should have policies against sexual harassment of sales reps. Such a policy may also help counter charges that a company is implicitly encouraging its reps to use their sexuality as a sales tool.

January 1st 2006

Legal: Shifting Perspective on Off-Label Promotion

By Jack Cinquegrana, Diana K. Lloyd
November 1st 2005

Legal: State Compulsory Licenses

By Tamsen Valoir
September 1st 2005

Legal: Jumping the Pond

By Mark Herrmann, Richard Elks
i1-170705-1408680993719.jpg
July 1st 2005

Legal Forum: Loss Causation

By Pamela S. Palmer, Jeff G. Hammel
Advertisement

Advertisement
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Prev
Advertisement
Advertisement

Trending on PharmExec

1

Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline

2

Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321

3

What the Peptide Advisory Vote Actually Means: Q&A with James LaValle

4

Pharmaceutical Executive Daily: Hanmi Licenses HM17321 to Genentech

5

Focusing on Asset Acquisition Over Building a Single Platform Technology

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us